← Zuruck zu CVEs
CVE-2013-1726
N/ABeschreibung
Mozilla Updater in Mozilla Firefox before 24.0, Firefox ESR 17.x before 17.0.9, Thunderbird before 24.0, Thunderbird ESR 17.x before 17.0.9, and SeaMonkey before 2.21 does not ensure exclusive access to a MAR file, which allows local users to gain privileges by creating a Trojan horse file after MAR signature verification but before MAR use.
CVE Details
CVSS v3.1 BewertungN/A
Veroffentlicht9/18/2013
Zuletzt geandert4/11/2025
Quellenvd
Honeypot-Sichtungen0
Betroffene Produkte
mozilla:firefoxmozilla:seamonkeymozilla:thunderbirdmozilla:thunderbird_esr
Schwachen (CWE)
CWE-264
Referenzen
http://lists.fedoraproject.org/pipermail/package-announce/2013-September/115907.html(security@mozilla.org)
http://lists.fedoraproject.org/pipermail/package-announce/2013-September/116610.html(security@mozilla.org)
http://lists.fedoraproject.org/pipermail/package-announce/2013-September/117526.html(security@mozilla.org)
http://www.mozilla.org/security/announce/2013/mfsa2013-83.html(security@mozilla.org)
https://bugzilla.mozilla.org/show_bug.cgi?id=890853(security@mozilla.org)
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A18821(security@mozilla.org)
http://lists.fedoraproject.org/pipermail/package-announce/2013-September/115907.html(af854a3a-2127-422b-91ae-364da2661108)
http://lists.fedoraproject.org/pipermail/package-announce/2013-September/116610.html(af854a3a-2127-422b-91ae-364da2661108)
http://lists.fedoraproject.org/pipermail/package-announce/2013-September/117526.html(af854a3a-2127-422b-91ae-364da2661108)
http://www.mozilla.org/security/announce/2013/mfsa2013-83.html(af854a3a-2127-422b-91ae-364da2661108)
https://bugzilla.mozilla.org/show_bug.cgi?id=890853(af854a3a-2127-422b-91ae-364da2661108)
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A18821(af854a3a-2127-422b-91ae-364da2661108)
IOC Korrelationen
Keine Korrelationen erfasst
This product uses data from the NVD API but is not endorsed or certified by the NVD.